Biological sample procurement company iSpecimen plans to establish a $200 million digital asset reserve and purchase SOL through OTC transactions.

ChainCatcher news, according to Investing, biospecimen procurement company iSpecimen Inc. (ISPC) announced that several cryptocurrency companies have approached it to offer investment opportunities. The company is planning to establish a digital asset portfolio valued at $200 million, aiming to diversify its balance sheet and support its growth plans through tokenized real-world assets and top-ranked cryptocurrencies.

iSpecimen is continuing parallel discussions to develop a financial plan based on the Solana blockchain. The company plans to purchase SOL through over-the-counter transactions with cryptocurrency institutions, including locked SOL with contract transfer or vesting restrictions.